Gawałko M, Kapłon-Cieślicka A, Hohl M, Dobrev D, Lin D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. Int J Cardiol Heart Vasc [Internet]. 2020 [cited 2022 Jan 4. 21];30 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462635/pdf/main.pdf

Sanchis-Gomar F, Perez-Quilis C, Lavie CJ. Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients? Eur Heart J [Internet]. 2020 [cited 2022 Jan 21];41(32):3092-3093. Available fromhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454510/pdf/ehaa509.pdf

Pattara R, Win S, Hicham EM, Sorajja D, Srivathsan K, Valverde A, et al.Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019.J Am Heart Assoc [Internet]. 2020 [cited 2022 Jan 21];9(14).Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660727/pdf/JAH3-9-e017529.pdf

Mujović N, Dobrev D, Marinković M, Russo V, S Potpara T. The role of amiodarone in contemporary management of complex cardiac arrhythmias. Pharmacol Res [Internet]. 2020 [cited 2022 Jan 21];151. Available from: https://www.sciencedirect.com/science/article/abs/pii/S104366181930430X?via%3Dihub

Ganatra S, Sourbha SD, Shah S, Asnani A, Neilan TG, Lenihan D, et al. Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic. Trends Cardiovasc Med [Internet]. 2020 [cited 2022 Jan 21];30(6):315–325. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255720/pdf/main.pdf